Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Home-based Photodynamic Therapy for Onychomycosis
NCT07012343Active, not recruiting
- Sponsor
- Chulalongkorn University
- Start
- Jan 2025
- Primary completion
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of methylene blue in onychomycosis (5 arms), sponsored by Chulalongkorn University. Primary endpoint: Mycologic Efficacy at 12 weeks. Started Jan 2025; status: active, not recruiting.
02
Drugs
methylene blue
03
Conditions
onychomycosis
Beyond the preview
Go deeper on NCT07012343.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07012343.